These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2258189)

  • 21. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Requirements for stimulation of autoreactive T cells by thymic stroma.
    Burstyn D; Zauderer M
    J Immunol; 1989 Sep; 143(5):1422-5. PubMed ID: 2474596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell immunity or tolerance as a consequence of self antigen presentation.
    Lin RH; Stockinger B
    Eur J Immunol; 1989 Jan; 19(1):105-10. PubMed ID: 2784102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell receptor/MHC interactions in the thymus and the shaping of the T cell repertoire.
    McDuffie M; Roehm N; Born W; Marrack P; Kappler JW
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):111-6. PubMed ID: 3321638
    [No Abstract]   [Full Text] [Related]  

  • 26. Neonatal tolerance induction in the thymus to MHC-class II-associated antigens. I. Preferential induction of tolerance to Mls antigens and resistance to allo-MHC antigens.
    Hosono M; Kina T; Hosokawa T; Katsura Y
    Cell Immunol; 1986 Nov; 103(1):1-10. PubMed ID: 3542233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymic expression of a gastritogenic epitope results in positive selection of self-reactive pathogenic T cells.
    Laurie KL; La Gruta NL; Koch N; van Driel IR; Gleeson PA
    J Immunol; 2004 May; 172(10):5994-6002. PubMed ID: 15128782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen presenting function of class II MHC expressing pancreatic beta cells.
    Markmann J; Lo D; Naji A; Palmiter RD; Brinster RL; Heber-Katz E
    Nature; 1988 Dec; 336(6198):476-9. PubMed ID: 3143077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance.
    Ramsdell F; Fowlkes BJ
    Science; 1990 Jun; 248(4961):1342-8. PubMed ID: 1972593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.
    Kruisbeek AM; Mond JJ; Fowlkes BJ; Carmen JA; Bridges S; Longo DL
    J Exp Med; 1985 May; 161(5):1029-47. PubMed ID: 3921649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cells inducing tolerance to Mls and H-2 antigens.
    Webb SR; Sprent J
    Adv Exp Med Biol; 1991; 292():149-57. PubMed ID: 1950766
    [No Abstract]   [Full Text] [Related]  

  • 32. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
    Holling TM; Schooten E; van Den Elsen PJ
    Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective suppression of T-cell activation by administration of MHC class II-binding peptides.
    Adorini L
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):14-6. PubMed ID: 1496683
    [No Abstract]   [Full Text] [Related]  

  • 35. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes.
    Tran CN; Davis MJ; Tesmer LA; Endres JL; Motyl CD; Smuda C; Somers EC; Chung KC; Urquhart AG; Lundy SK; Kovats S; Fox DA
    Arthritis Rheum; 2007 May; 56(5):1497-506. PubMed ID: 17469112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accessory cell presentation of hapten-modified self.
    Cogswell JP; Scott DW
    Surv Immunol Res; 1985; 4(4):303-12. PubMed ID: 2941842
    [No Abstract]   [Full Text] [Related]  

  • 37. On the complexity of self.
    Rudensky AYu ; Rath S; Preston-Hurlburt P; Murphy DB; Janeway CA
    Nature; 1991 Oct; 353(6345):660-2. PubMed ID: 1656278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
    Kovacsovics-Bankowski M; Rock KL
    Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell contact with Ia antigens on nonhemopoietic cells in vivo can lead to immunity rather than tolerance.
    Gao EK; Kosaka H; Surh CD; Sprent J
    J Exp Med; 1991 Aug; 174(2):435-46. PubMed ID: 1677393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen presentation by cells that are not of bone marrow origin.
    Geppert TD; Lipsky PE
    Reg Immunol; 1989; 2(1):60-71. PubMed ID: 2518360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.